ALPS Medical Breakthroughs ETF (SBIO)Health | Exchange Traded Fund | NYSEArca
57.60 USD
+1.23
(2.182%)
⇧
(April 17, 2026, 3:59 p.m.
EDT)
After hours: 58.00 +0.40 (0.694%) ⇧ (April 17, 2026, 5:35 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ★★☆☆☆ |
Hot Take | April 11, 2026, 1:37 p.m. EDT
SBIO has shown recent price momentum, with a recent close near its 52-week high, and positive news headlines pointing to potential growth in the biotech sector. However, the dividend history is inconsistent, with a significant drop in 2023. While the options data suggests some bullish sentiment, the overall risk-reward balance is moderate. Investors should consider the recent price movement and news flow, but the lack of consistent dividends and mixed options activity suggest a cautious approach. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.027744 |
| AutoTheta | 0.030656 |
| MSTL | 0.031847 |
| AutoARIMA | 0.051195 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 52% |
| H-stat | 3.46 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.734 |
| Excess Kurtosis | -0.57 |
As of April 11, 2026, 1:37 p.m. EDT: Options activity shows mixed signals. For the April 17 expiration, there is significant call volume and open interest around the 50.0 strike, indicating bullish sentiment. However, the put volume is low, suggesting limited bearish positioning. For the July 17 expiration, calls are concentrated around the 50.0 and 56.0 strikes, while puts are more active around the 55.0 strike. This could indicate a cautious bullish stance with some short-term downside protection. The low volatility and open interest in the October 16 expiration suggest reduced activity and less immediate directional speculation.
| Date | Dividend | Yield % |
|---|---|---|
| 2024-12-19 | 1.174 | 3.524150 |
| 2023-12-21 | 0.071 | 0.237798 |
| 2019-12-19 | 0.016 | 0.038922 |
| 2018-12-20 | 0.784 | 2.988979 |
| 2017-12-21 | 0.579 | 1.911846 |
| Attribute | Value |
|---|---|
| All Time High | 64.04 |
| All Time Low | 19.18 |
| Ask | 60.65 |
| Ask Size | 100 |
| Average Daily Volume10 Day | 24,500 |
| Average Daily Volume3 Month | 33,019 |
| Average Volume | 33,019 |
| Average Volume10Days | 24,500 |
| Beta3 Year | 1.16 |
| Bid | 54.44 |
| Bid Size | 1,800 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 57.77 |
| Day Low | 57.02 |
| Dividend Yield | 0.0 |
| Esg Populated | 0 |
| Exchange | PCX |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 51.36284 |
| Fifty Day Average Change | 6.2371597 |
| Fifty Day Average Change Percent | 0.12143332 |
| Fifty Two Week Change Percent | 109.94413 |
| Fifty Two Week High | 57.77 |
| Fifty Two Week High Change | -0.17000198 |
| Fifty Two Week High Change Percent | -0.0029427381 |
| Fifty Two Week Low | 26.285 |
| Fifty Two Week Low Change | 31.314999 |
| Fifty Two Week Low Change Percent | 1.1913638 |
| Fifty Two Week Range | 26.285 - 57.77 |
| First Trade Date Milliseconds | 1,420,036,200,000 |
| Five Year Average Return | 0.0398027 |
| Full Exchange Name | NYSEArca |
| Fund Family | ALPS |
| Fund Inception Date | 1,419,897,600 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. |
| Long Name | ALPS Medical Breakthroughs ETF |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_275139748 |
| Nav Price | 56.2956 |
| Net Assets | 131,986,800.0 |
| Net Expense Ratio | 0.5 |
| Open | 57.23 |
| Phone | 855.724.0450 |
| Post Market Change | 0.40000153 |
| Post Market Change Percent | 0.6944471 |
| Post Market Price | 58.0 |
| Post Market Time | 1,776,461,747 |
| Previous Close | 56.37 |
| Price Hint | 2 |
| Quote Source Name | Delayed Quote |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 1.23 |
| Regular Market Change Percent | 2.18201 |
| Regular Market Day High | 57.77 |
| Regular Market Day Low | 57.02 |
| Regular Market Day Range | 57.02 - 57.77 |
| Regular Market Open | 57.23 |
| Regular Market Previous Close | 56.37 |
| Regular Market Price | 57.6 |
| Regular Market Time | 1,776,455,990 |
| Regular Market Volume | 27,969 |
| Short Name | ALPS Medical Breakthroughs ETF |
| Source Interval | 15 |
| Symbol | SBIO |
| Three Year Average Return | 0.2845019 |
| Total Assets | 131,986,800 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 2.24332 |
| Trailing Three Month Returns | 2.24332 |
| Triggerable | 1 |
| Two Hundred Day Average | 44.32051 |
| Two Hundred Day Average Change | 13.279488 |
| Two Hundred Day Average Change Percent | 0.29962397 |
| Type Disp | ETF |
| Volume | 27,969 |
| Yield | 0.0 |
| Ytd Return | 2.24332 |